Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better since.
https://vimeo.com/652106617
$PBIO,...
FDA approves Amgen drug for tough-to-treat form of lung cancer.
Known scientifically as tarlatamab, Indelltra is only for patients once they progress following chemotherapy. On chemotherapy alone, patients can expect to live on average...
Revive Therapeutics (RVVTF, RVV): Updates and News Archive.
Recent Headlines
(See FDA Filing Submission at Bottom)
LIVE QUOTE
NEWS ARCHIVE INTRO
“These medicines have a sweet spot. If the day you get diagnosed with COVID you...
Surna Cultivation Technologies Signs $2.1 Million Contract
This is the 4th Multi-Million Contract Awarded in the Last Couple Years, With Three in 2022 Alone!
LIVE CHART
An Additional Multi-Million Dollar Contract Signed for HVACD Systems
Louisville, Colorado, March...
Provention Bio (PRVB) Updates.
LATEST UPDATE July 13th, 2022, below.
(2021) We're getting way too many calls on this. We'll try to put a blow by blow here. Nothing...
Psycheceutial Biosciences (BWVI) Listed on WeFunder!
Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated.
Imagine the benefits of psychedelics, without hallucinating!
Our Favorite small Psychedelic company Psycheceutical Bioscience is using...
Resuming Coverage on PetVivo (PETV).
After Being up 1,035%, Raising $11 Million, Upgrading to NASDAQ, and Retreating 87% From its High, we Resume Coverage.
PICTURE TELLS A STORY: LIVE...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a biotechnology company...
China Remains at Risk to Future MonkeyPox Outbreaks.
GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.
The World Health Organization just updated global...
Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to Prilosec ® ....
Latest article
Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.
'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface.
Led by legendary geologist Dr. Sergei...
New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.
Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...
Replimune (REPL) Jumps 100%.
A Nifty $415 Million Gain (in an hour) for Shareholders.
Not out of the woods yet..
Short and to the point: We listened to whole meeting...
